You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. RASP- Automated Scoring Program for Rodent Ultrasonic Vocalizations (USVs)

    SBC: Mide Technology Corporation            Topic: DHP16C003

    Rodents serve as models for the human brain and behavior, and their calls give researchers a window into their mood. Unfortunately, rodent calls are ultrasonic, so a researcher must record a test and then play the audio back at a slower speed to manually categorize and count calls. Software does exist to accomplish this task, but it does not have the ease of use or accuracy that researchers want. ...

    STTR Phase II 2018 Department of DefenseDefense Health Agency
  2. Portable, Non-Contact, Quantitative, Physiology and Health Assessment Imaging System

    SBC: BODKIN DESIGN & ENGINEERING LLC            Topic: DHP16C005

    Accurate assessment of burn depth and surface area are important to clinical decision-making regarding treatment. Initial assessment determines fluid requirements and transportation decisions to distant-care facilities. The clinician must determine if the wound will heal itself or whether excision and grafting are necessary for optimal wound healing. The standard of care remains visual inspection ...

    STTR Phase II 2018 Department of DefenseDefense Health Agency
  3. Novel Circulating RNA-based Markers as Diagnostic Biomarkers of Infectious Diseases

    SBC: CFD RESEARCH CORPORATION            Topic: CBD18A001

    In resource limited settings, rapid and accurate diagnosis of infections is critical for managing potential exposures to highly virulent pathogens,whether occurring from an act of bioterrorism or a natural event. This is especially important for hard to detect intracellular bacterial andalphavirus infections, that overlap symptomatically and often treated empirically due to a lack of reliable and ...

    STTR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense
  4. Marburg Virus Prophylactic Medical Countermeasure

    SBC: MAPP BIOPHARMACEUTICAL, INC.            Topic: CBD18A002

    There are currently no vaccines or therapeutics available for Marburg Virus Disease (MVD). Given the specter of weaponization and the terriblemorbidity and high mortality rate of MVD, this represents a critical threat to the operational readiness of the Warfighter. While traditionalvaccines have proven to be a huge contribution to public health, they do have some limitations especially in the cont ...

    STTR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense
  5. Host-Targeted Antiviral Drugs Providing Rapid, Scalable, Stable, Broad-Spectrum MedicalCountermeasure Against Marburg Virus

    SBC: EVRYS BIO LLC            Topic: CBD18A002

    In a pandemic or exposure to weaponized Marburg virus the morbidity, mortality and social unrest that will ensue before vaccines orMilitary operating on foreign soil as well as to the population of the US Homeland. Practically all threat agents of biological origin (except forcertain non-proteinaceous toxins, typically produced by marine organisms and fungi) have their structure and vital function ...

    STTR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense
  6. Marburg Virus Prophylactic Medical Countermeasure

    SBC: Flow Pharma, Inc.            Topic: CBD18A002

    Flow Pharma, Inc. is a biotechnology company in the San Francisco Bay Area developing fully synthetic cytotoxic T lymphocyte (CTL)stimulating peptide vaccines for Marburg virus. The FlowVax vaccine platform allows us to create dry powder formulations of biodegradablemicrospheres and TLR adjuvants incorporating class I and class II T cell epitopes. FlowVax vaccines can be designed for delivery by i ...

    STTR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense
  7. Wireless Non-Invasive Advanced Control of Microprocessor Prostheses and Orthoses

    SBC: LIBERATING TECHNOLOGIES INC            Topic: DHP17A005

    There are several current and imminent orthotic and prosthetic (O&P) fitting scenarios that would greatly benefit from the ability to wirelessly collect and transmit physiological information from the user. Both upper- and lower- limb O&P fittings that: 1) use osseointegration, 2) have cable management issues, and 3) could benefit from physiological information from locations proximal to the prost ...

    STTR Phase II 2018 Department of DefenseDefense Health Agency
  8. Bio-magnetic Detection of Neuromuscular and Wound Related Injuries

    SBC: TRITON SYSTEMS, INC.            Topic: DHP17A001

    It is generally recognized that the human body transmits electro-magnetic fields (EMF). The Phase I program demonstrated a practical solution to detect these emissions. The technology was shown to be compatible for integration into wearable textiles. The Phase 2 program will focus on demonstrating the capability of discriminating between healthy and injury related EMF emissions such that it can be ...

    STTR Phase II 2018 Department of DefenseDefense Health Agency
  9. Fast Parameter Identification for Personalized Pharmacokinetics

    SBC: AUTONOMOUS HEALTHCARE INC            Topic: DHP17B003

    Drug dosingcan bemademore precise by using pharmacokineticand pharmacodynamicmodeling. Pharmacokinetics is thestudy of the concentration of drugs in tissueasafunction of timeand doseschedule,whereas pharmacodynamics is thestudy of therelationship between drugconcentration and drugeffect. By relating doseto resultant drugconcentration (pharmacokinetics)and concentration to effect (pharmacodynamics) ...

    STTR Phase I 2018 Department of DefenseDefense Health Agency
  10. A Portable Multimodality System for in-field Airway Injury Assessment and Compliance Measurement

    SBC: RADIATION MONITORING DEVICES, INC.            Topic: DHP16C006

    Airway compromise is the third leading cause of potentially preventable death on the battlefield. Current evaluation techniques of the airways associated with smoke inhalation injury are highly subjective and lack the sensitivity required of an accurate diagnostic and assessment tool. The problem of detection is further compounded by the late onset of symptoms that in many cases do not present unt ...

    STTR Phase II 2018 Department of DefenseDefense Health Agency
US Flag An Official Website of the United States Government